CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for JiangSu WuZhong Pharmaceutical Development Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

JiangSu WuZhong Pharmaceutical Development Co Ltd
No. 988
Dongfang Avenue, Wuzhong District
Phone: +86 51266981888p:+86 51266981888 SUZHOU, JNG  215124  China Fax: +86 51265270086f:+86 51265270086
This company is no longer actively traded on any major stock exchange.
Business Summary
JiangSu WuZhong Pharmaceutical Development Co Ltd is a China-based company principally engaged in pharmaceutical and medical aesthetics biotechnology businesses. The Company operates its businesses through four segments. The Headquarters Assets and Other Industries segment primarily engages in businesses related to headquarters assets. The Pharmaceutical segment is mainly engaged in drug research and development, manufacturing, and sales, with its main products covering areas such as antiviral, anti-infective, immunomodulatory, anti-tumor, digestive system, and cardiovascular drugs. The Medical Aesthetics and Biotechnology segment focuses on medical aesthetics injectable products, developing its product pipeline through external introductions, collaborative research and development, and independent research and development. The Investment segment primarily engages in related investment businesses.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, General Manager QunshanQian 50 3/22/2024 3/20/2020
Vice Chairman of the Board QunyingQian 55 3/22/2024 3/31/2021
Vice President, Deputy General Manager, Secretary of the Board TiejunGu 43 3/22/2024 3/31/2021
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Jiangsu Wuzhong Group
Jiangsu Wuzhong Industrial Co., Ltd
Xiangshui Henryda Technological Chemical Co., Ltd.

General Information
Number of Employees: 1,096 (As of 12/31/2024)
Outstanding Shares: 710,879,480 (As of 9/30/2025)
Shareholders: 62,089
Stock Exchange: SHA
Fax Number: +86 51265270086


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, January 8, 2026